Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank A Post

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
AIDS (London, England)|February 23, 2017
Bone mineral density decline in patients on stable antiretroviral therapyFrank A Post
The Lancet. HIV|January 15, 2016
Should kidney disease risk affect antiretroviral choice?Frank A Post
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Pellagra: a rare complication of isoniazid therapyFrank A Post
Current Opinion in Infectious Diseases|November 10, 2016
Managing chronic kidney disease in the older adults living with HIVFrank A Post
Antiviral Therapy|January 18, 2021
Correcting eGFR for the effects of ART on tubular creatinine secretion: does one size fit all?Frank A Post, Lisa Hamzah
International Journal of STD & AIDS|September 21, 2021
Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis BNisha Patel, Frank A Post
AIDS (London, England)|June 2, 2022
Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are neededFrank A Post, Phumla Sinxadi
AIDS (London, England)|January 4, 2021
Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravirLisa Hamzah, Frank A Post
Current Opinion in Infectious Diseases|December 25, 2008
Recent developments in HIV and the kidneyFrank A Post, Stephen G Holt
Lancet (London, England)|September 9, 2008
Abacavir and increased risk of myocardial infarctionFrank A Post, Lucy J Campbell
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|February 23, 2017
Bone mineral density decline in patients on stable antiretroviral therapyFrank A Post
The Lancet. HIV|January 15, 2016
Should kidney disease risk affect antiretroviral choice?Frank A Post
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Pellagra: a rare complication of isoniazid therapyFrank A Post
Current Opinion in Infectious Diseases|November 10, 2016
Managing chronic kidney disease in the older adults living with HIVFrank A Post
Antiviral Therapy|January 18, 2021
Correcting eGFR for the effects of ART on tubular creatinine secretion: does one size fit all?Frank A Post, Lisa Hamzah
International Journal of STD & AIDS|September 21, 2021
Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis BNisha Patel, Frank A Post
AIDS (London, England)|June 2, 2022
Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are neededFrank A Post, Phumla Sinxadi
AIDS (London, England)|January 4, 2021
Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravirLisa Hamzah, Frank A Post
Current Opinion in Infectious Diseases|December 25, 2008
Recent developments in HIV and the kidneyFrank A Post, Stephen G Holt
Lancet (London, England)|September 9, 2008
Abacavir and increased risk of myocardial infarctionFrank A Post, Lucy J Campbell
Pageof 18